XML 62 R28.htm IDEA: XBRL DOCUMENT v3.24.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2023
Stock-Based Compensation [Abstract]  
Stock-Based Compensation Expense

The following table summarizes the components of stock-based compensation expense in the consolidated statements of operations and comprehensive loss for the years ended December 31, 2023 and 2022:

   
Year Ended December 31,
 
   
2023
   
2022
 
Research and development
 
$
3,013,326
   
$
1,868,352
 
General and administrative
   
4,600,995
     
3,327,804
 
Total
 
$
7,614,321
   
$
5,196,156
 
Stock Option Activity

The following table summarizes the stock option activity for the Company’ stock option plans for the year ended December 31, 2023:

   
Number
of Shares
   
Weighted
Average
Exercise Price
   
Weighted
Average
Remaining
Contractual
Life in Years
   
Aggregate
Intrinsic Value
 
Balance at January 1, 2023
   
4,171,311
   
$
5.56
     
7.89
      32,779,920  
Granted
   
1,414,000
   
$
10.31
      9.18       290  
Exercised
   
(81,935
)
 
$
3.77
             
Forfeited
   
(456,405
)
 
$
10.64
             
Expired
    (17,626 )     16.17                  
Options outstanding at December 31, 2023
   
5,029,345
   
$
6.43
     
7.42
   
$
4,395,227
 
Vested and expected to vest at December 31, 2023
   
5,029,345
   
$
6.43
     
7.42
   
$
4,395,227
 
Exercisable at December 31, 2023
   
2,829,330
   
$
5.60
     
6.53
   
$
3,315,101
 
Assumptions Used to Value Options and Warrants Granted

The fair value of options granted during the year ended December 31, 2023 and 2022 were estimated using the Black-Scholes option valuation model utilizing the following assumptions:

   
Year Ended December 31,
 
   
2023
   
2022
 
   
Weighted Average
 
Volatility
   
142.84
%
   
99.63
%
Risk-Free Interest Rate
   
4.14
%
   
1.79
%
Expected Term in Years
   
6.06
     
6.39
 
Dividend Rate
   
     
 
                 
Fair Value of Option on Grant Date
 
$
9.59
   
$
4.40